Half year report 2021
The Galenica Group experienced strong growth in the first half of 2021. This was due in particular to one-off additional sales in connection with COVID-19, Verfora’s portfolio expansion, a pleasing increase in sales of the specialty pharmacy Mediservice and further market share gains in the physicians segment.
The Galenica Group generated consolidated net sales of CHF 1,857.1 million in the first half of 2021, corresponding to growth of 9.9% compared to the first half of 2020.
1,857.1
Net sales
in CHF million
101.4
EBIT adjusted1
in CHF million
7,095
Number of employees
at 30 June 2021
Products & Care
Development and marketing of healthcare services and products
The “Products & Care” segment comprises the “Retail” business area with offerings for patients and end customers (B2C) and the “Professionals” business area with offerings for business customers and partners in the healthcare sector (B2B).
Read moreLogistics & IT
Optimisation and further development of logistics offer and services
The “Logistics & IT” segment comprises the two sectors “Wholesale” and “Logistics & IT Services”. These provide services for all those involved in the healthcare sector – pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.
Read more